Report #2843185

Received May 29, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 95 yrs
State: CT
Recovered: Unknown
Vaccinated: May 23, 2025
Onset: May 23, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	J32PB	—

Symptoms (1)

Product preparation issue

Symptom narrative

administration of only adjuvant component of the Shingrix; administration of only adjuvant component of the Shingrix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 95-year-old female patient who received Herpes zoster (Shingrix) (batch number J32PB, expiry date 31-MAR-2027) for prophylaxis. On 23-MAY-2025, the patient received Shingrix. On 23-MAY-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: administration of only adjuvant component of the Shingrix) and inappropriate dose of vaccine administered (Verbatim: administration of only adjuvant component of the Shingrix). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 23-MAY-2025 The nurse requested guidance and data regarding how to proceed following the administration of only the adjuvant component of the Shingrix vaccine which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.